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Pemphigus vulgaris and pemphigus foliaceus are cutane-
ous autoimmune diseases characterized by intraepithelial 
blisters and autoantibodies to desmosomal glycoproteins. 
The antigens recognized by pemphigus vulgaris and 
pemphigus foliaceus autoantibodies are desmoglein-
3 (Dsg3) and desmoglein-1 (Dsgl), respectively. Dsg3 
and Dsgl are members of the desmoglein subfamily of 
the cadherin supergene family of cell adhesion molecules . 
It has been well documented that a subset of pemphigus 
vulgaris sera have IgG reactivity to both Dsgl and Dsg3, 
suggesting that Dsgl may also participate in the auto-
inunune response of these patients. The cellular median-
isms ofT cell autoimn:nmity in these patients, however, 
are completely unknown. In this study, we tested the 
proliferative responses of T lymphocytes from eight 
pemphigus vulgaris patients after incubation with Dsg3 
and Dsgl fusion proteins. The sera of four of these PV 
P emphigus vulga tis (PV) and pemphigus folia ceus (PF) are autoantibody-mediated cutan eous diseases characteri zed by intraep idermal blisters and pathogenic anti-desmosoma l autoantibodies (Beutner and J ordon, J 964; Lever, 1965; Stanley c/ a/, 1984). Based on cli nica l, histologic, and 
immun ologic find in gs, PV and PF are distin ct autoimmune diseases. 
ln PV, th e disease affects skin and mu cosal epithelia and aca nth olysis 
is observed in th e suprabasilar layer, w hereas in PF, the disease is 
epidermal specific and ce ll-cell detachm ent occurs within the subcor-
neal layer (Civatte, . 1943; Lever, 1965). PV and PF anti -epidermal 
autoantibodies were first shown to be pathogenic by passive transfer 
experim ents using neonatal BALB/C mice (Anhalt eta /, 1.982; Roscoe 
el al, 1985; Futamura et al , 1989) . T hese murine models reproduced 
the classic cl.inica l and bisto l.ogic featurt!s of th ese two human diseases. 
The predominant lgG isotype of the pathogenic anti-epidennal auto-
antibodies in both diseases is lgG4 Qones ct a/, 1988; R ock et a/, 1989; 
Allen et a/, 1993; Bhol ct a/, 1994). 
T he autoantigens recognized by PV and .PF autoantibodies have 
been identified as desmoglein -3 (Dsg3) (S tanley et a/, 1984; Amagai 
et a/, 1991) and desmoglein- 1 (Dsgl) (S tanley et a/, 1984; Wh eeler 
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patients showed reactiVIty with both Dsgl and Dsg3, 
whereas the retnaining four reacted only with Dsg3. We 
found that T cells obtained from those patients that 
exhibited the combined Dsg1/Dsg3 autoantibody react-
ivity showed a proliferative response after exposure to 
either Dsgl or Dsg3 fusion proteins. The cellular 
responses to both of these recombinant proteins were 
highly specific and restricted to the CD4-positive T cell 
population. T cells from pemphigus vulgaris patients 
with no anti-Dsgl sermn. reactivity showed a proliferative 
response to Dsg3, but not to Dsgl. The Dsgl fusion 
protein used in this study has minimal sequence homo-
logy with Dsg3. Thus, this study provides the first evid-
ence that T cells from a subset of pemphigus vulgaris 
patients respond to both Dsgl and Dsg3. Key words: 
autoantibodies I autoimmunity I bullous diseases I desmosome. ] 
I1west Demratol 109:734--737, 1997 
cl a/, 1991), respectively. The J 60-kDa Dsg1 and the 130-kDa D sg3 
are transmembrane desmosomal glycoproteins, and botb are members 
o f the desmoglein subfami ly of the cadherin supergene f.omily (Buxton 
and Magee, '1992). It has been reported recently that recombinant 
Dsg1 and Dsg3 generated in th e baculovirus express ion system are 
capable of adso rbing pathogenic autoa ntibodi es fi·om the sera of the 
respective patients (Amagai et a/, 1994, 1996). These experim ents 
provide strong evidence tha t autoa ntibodies aga inst Dsgl and D sg3 
participate in the immune injury of epidermis and mucosal tissues in 
pati ents with PF and PV, respecti vely. 
In addition to anti-Dsg3 autoa ntibodies, =50% ofPV sera recognize 
Dsg1 (Eyre and Sta nley, 1988; Amagai et a/, 1994; Emery ct a/, 1995). 
The signifi cance of these anti -Dsgl autoa ntibodi es in th e pathogenesis 
of PV remains unkn own. Interestingly, certain patien ts appear to show 
a clinical , histologic, and immunologic transition fi·om PV to PF 
(lwa tsuki eta/, 1991; Kawana eta/, 1994; Hashim oto c/ a/, 1995). Sera 
from this particular subset of PV patients react with the extracellular 
domain of Dsgl by immunoblotting, immunoprecipitation, and 
immunoBuorescence (TF) techniqu es (Emery ct a/, 1995; Kowalczyk 
ct a/, 1995) . 
In this communication, we report that T cells fi·om a subset of fo ur 
PV patients whose sera immunoprecipitate Dsg .l , proliferate in response 
to a segment of Dsgl that shares minim a] homology with the 
co rresponding region ofDsg3. The proliferative response ofT cells to 
Dsgl is specific and reprodu cible. Our data therefore prov ide the first 
direct evidence that both Dsgl and Dsg3 are invo lved in the auto-
immune responses in a particular subset of PV patients that share in 
common anti-Dsg1 and anti -D sg3 autoantibodies. Furthermore, we 
demonstrate that th e Dsgl -specific T cells fi·om this subset o f PV 
patients exhi bit the CD4, but no t the CDS, cell marker. Future 
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Table I. Dsgl and Dsg3 can stim.ulate T cells from PV patients w ith a combined anti-Dsgl / Dsg3 autoantibody response 
lmn1uno,p recipitatio n11 T cel l proli fe rotion1' 
Potietl t' Diseose Dsg 'l Dsg3 Dsg1 (FP-K) Dsg3-A' Dsg3-Br Dsg3-C" SL'l 'l GST 
duration 
EG 2 y + + 30.6 27 .5 13.0 24.0 (-) (-) 
WAF 2 y 5 111 0 + + 12.0 85.0 45.6 28.0 (-) (-) 
NW '\ y 9 1110 (-) + (-) 17.0 6.0 6.3 (-) (-) 
LS 5 y 8 mo + + '12.0 10.0 8.0 9.0 (-) (-) 
UP 5 1110 (-) + (-) l3.0 16.0 10.0 (-) (-) 
EF 2 y 7 111 0 (-) + (-) 5.0 4.0 3.0 (-) (-) 
WE 3 y 2 1110 + + 10.0 4.0 (-) 7.0 (-) (-) 
ML 'J y 8 mo (-) + (-) 6.0 5.0 3.0 (-) (-) 
11T hc presence of :-~m ibod i es to Dsg l and Dsg3 wc1'e detected by imJnu noprcc.ipitation as described in Nfatcritlls aud A1etltods. 
1
'T cell prolifc ratiOi l assays were :~pp li cd to dercn 11ine th e responses of T lytl lphocytes to Dsg l , Dsg3 . Jnd Sfi l fusi011 prorci 11 S. D :lta :~ rc prese nted in tcr1ns of the srimul:l tion index. A 
stimulati o n index eq ur~l to o r greater than three.:: is co nsidered a positivc respo nse . T ce lls that do not respond co stimulation :m.! indic:-t ted as (-). 











Figute 1. Dsgl and Dsg3 fus ion proteins . Both Dsg l ~nd Dsg3 contoin 
five major codherin- li ke domoi ns on th ~ extracellulat· portion. T he black strips 
are the Co2-!- binding sites . T he l oc~ti o ns of I sg'l ond Dsg3 fusion proteins 
used in this study are shown as horizontal bars. 
charac terizatio n of T cell responses in these patie nts w ill help to 
e lu cidate th e m ecbanjsm(s) responsibl e fo r d isease progression and may 
sh ed li gh t o n th e transition of PV to PP. 
MATERIALS AND METHO DS 
PV patients and controls Sera and peripherol blood tnononucleor cells 
(PBMC) were obtained tj·om eight we ll-characte ri zed PV patiems, who were 
followed at the D epartment of Dermatology C lini cs of the Medica l College of 
Wisconsin. T he PV patients included in this study showed positive direct ond 
indirect IP studies . Potients with other cutaneous outo immune d ise~se, such as 
bullous pemphigo id (BP) (n = 3), cicotri ciol pemphigoid (CP) (n = 2), and 
psori~sis (n = 4) , were included olong with norn1al volu nteers (n = 8) os contro ls. 
Preparation of Dsg3 and Dsgl fusion proteins To evaluote the response 
of T cells of PV patients to Dsgl , we generated a bacteriol fusion protein 
(designoted FP- K; Fig 1) containing ~ portion of the ES regio n of l sgl , which 
shows minimal sequence homology with Dsg3 (see Resu/t.s). \~egions El- E4 of 
Dsg1 , which exhibit 55 .9'){, sequence identity with Dsg3 (Amagai c£ a/. :1 99 1), 
\Vere avo idt:d to n1in intize pocenti:1 l crOS:i-reactiviry problem.s. To generate 
fusion protein K (FP-K), the Dsgl eDNA segment encoding :tmino ocids 424-
s ·l 0 was r o lymerase elw in reaction a111 pli fied and subcloned in to rit e bacceri:tl 
expression vector pGEX2T (Pharmacia, Piscataway, NJ ) ~s previously desctibed 
(Liu et a/, 1995). T he resul ting fusion pro tein consisted of glutathione S-
tronsferose (GST) fused to the Dsg1 peptide made up of the following sequence: 
RTCTGT IN l N I QSFGNDDRTNTEPNTKITTNTG RQ ESTSSTNY DTST-
TSTDSSQVYSS.E l'GN GAI(l)LLSONVHFGI'A .IGLLIMGFL. Also used i11 
this study were GST-Dsg3 fusio n proteins A, B, ond C cont:t ini11g Dsg3 omino 
acids 145-192, 240-303, and 570-61-1, respectively. The Dsg3 fusion proteins 
were olso generated using the pGEX express ion system and were described in 
o recent public~tion (Lin el a/ , \997b; Fig 1). T he recombinant Dsgl and Dsg3 
prote ins were expressed in Esdte~icltia coli strain DHSa and purifi ed by 
glu tathione-agarose affi ni ty chro motograp hy (Liu cr a/, '1992) . T he purified 
fusion protei ns were di~ l yzed :tgainst phosphore-buffered saline, concentrated 
by ultrafi.ltration, and filter-sterili zed. T he protein conccmra tion was de termined 
by Bradfo rd protein ossoys (B io-Rad, Hercules, CA) . ' 
Innnunoprecipitation of Dsgl and Dsg3 T he presence of anti-Dsg3 
a11d ~ nti -Dsg'l outoontibodies in sero fi·om PV potie n t~ was detected by 
it nmunoprecipi tation as described (Lo bib cr a/, 1990) . The ectodomain ofDsg3 
used in this experiment wos prepared using a baculovirus expression system 
(A magai cl nl, '1994), whereas Dsgl immunoreacti ve tryptic fragments were 
obtained from bovine snout ep idennis fo ll owing procedures described by our 
bborato ty (Olague-Alcala r l a/, 1994). Both Dsg3 and the tty ptic fra gments of 
Dsg'l were labeled with 125 1 fo ll owing the chloranune T method (Calvan ico 
cr 11/, 199 \ ; Iague-Alcala and Din, \ 993). 
Purification of peripheral blood mononuclear cells and isolation of 
CD4 + and CD8 + T cells PBI'v\C were isolated by Picoll - Hypaque (Phorma-
cia) density grad ient separotion (Vila era/, '1995). T cells were then purified by 
E-rosetting using 2-amino-ethyLisothiouronium bromide (Sigma, St. Louis, 
MO)- treatcd slwep red blood cells (Colorado Serum, Denver, CO) (lndiverr:i 
er a/, 1980) . C 4+ or CD~+ T lymphocytes were further purified fro m the 
to tal T ceLl population by nego tive selection using a mognetic cdl sorter 
(Miltenyi Biotec, Auburn , C A) combined with ~nti-CD8 (B iosource, Conmillo, 
C A) or anti -CD4 antibodies (Biosource) (Miltenyi er a/, 1989). The purity of 
the CDH and C DH+ cdl isolates was greater thon 98% as determined by 
Au oresccnce-acti voced cell sorter ~ n a lysi s (not shown). T he pmitied T cells 
were w:tshed with medi um three ti mes, and resuspended in RPM I1640 medium 
supplemented with 10% human AB serum (NAB!, Miami , FL) to r the T cell 
proli fe ration assays. 
T cell proliferation assays T ce ll responses to Dsg l and Dsg3 fi.1sion proteins 
were determined by pro life ration ass.1ys os desc1ibed (.Lin et a/, :1997b). Briefl y, 
T cells ot a density of 10:; per ml were cultured with 105 pe r ml of irradiated 
outologous PBMC os antigen- presenting cells in wel.ls of 96-well U-botton1 
places fo r 7 d. Phytohemagglu tinin (S igma) at 0.25 ~g per mJ or \L-2 at 10 U 
per ml served as positive controls itt ~ u T cell proli fe ration expe1iments. T he 
GST-BP180 fusion pro tein Sd I (G iudice ,., 11i, 1993, 1994) was :tlso included 
in this study. Cells in individual wells were pulsed with 1 ~LCi of l3H]thymidine 
(IC N) during chc lose 18 h of incubation and then harvested using on automated 
cell harvester (lnotech Biosys tems, Lansing, Ml). T he pro liferotion ofT cells 
was detennined by measuring the l31-J]thymidine uptake on o ~-coun ter (Wallac, 
Ga ithersburg, MD). Data were presented os overage cpm ::':: SD or stimulation 
index (cpm of cells tt·eated with fusion proteins ~ cpm of cells treated wi th 
GST n the scune concentration). A stimulation index equal to or greater than 
three was considered o positive response. 
RESULTS 
Sera from a subset ofPV patients in:ununoprecipitate Dsg3 a nd 
Dsg1 T he se ra fro m the eight PV patients inclu ded in this study 
were: ana.l yzed by immuno precipitation for reactiviry w ith D sgl and 
Dsg3 , and the results are presen ted in Table I . For use in chis an alysis, 
a recombinant pro tei n en compassing th e entire extrace.l luJar domain 
ofDsg3 was produ ced in th e b;1culovim s system. T his 66-kDa protein 
was immunoprecipitated by all eight PV sera , but not by any of th e 
control sera. A radio-iodinated epiderm al prepJration containing a 45-
kDa tryp ti c fragm ent of bovin e Dsg l was also used to test the PV and 
control sera . This 45-kDa D sgl p eptide, w hich bas previo usly been 
shown co b e recognized b y all P F sera and a subset of PV sera (Olagu e-
Alcala ct a/, 1994), was immunoprecipitated by fou r of the e ight PV 
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Figure 2. T lymphocytes from a subset of PV patients proliferate in 
response to Dsgl FP-K. T he pro l i fe r~ tive responses of T cells from a 
representati ve PV patient to the FP-K were exanuned as described in Nlaterials 
and Met.lwds. T he responses of the total T cdl population (a), 0 4+ 1' cel.ls (b) , 
and CD8+ T cells (c) to this Dsg1 peptide were detenn ined by eHJthynudine 
incorporation. Data we re expressed as ave rage cpm + SO. 
sera in this study. None of the control sera reacted with this D sgl 
peptide. Thus, these results demonstrate unequivoca lly that sera fi·om 
these four PV patients react with both Dsgl and Dsg3. 
T lymphocytes front a subset ofPV patients respond to a D sgl 
fusion protein Previously, we have identified three peptide segments 
on the ectodomain of D sg3 that are recognized by T cells fro m PV 
patients (Li n ct a/, l 997b). T hese D sg3 peptides indu ce pro liferation 
ofT cells from PV patients in a concentration-dependent manner. To 
furth er examin e wheth er T lymphocytes fi·om th ese PV patients 
respond to Dsgl , proli feration as ays were perfo rmed using FP-K that 
encompasses amino acids 424-510 of Dsg1. This Dsg1 peptide was 
chosen because its amino ac id sequ ence was highly divergent from that 
T HE JO URNAL O F INVESTIGATI VE DERMATOLOGY 
of the coJTesponding region of Dsg3. Based on sequ ence comparisons 
between the FP-K insert and th e entire human D sg3 ectodomain using 
FASTA and BESTFIT [Wisconsin Package Version 9.0, Genetics 
Com.pute r Group (G C G) , Madison, WI], th e longest stretch of identical 
residu es was three. After allowing for conserva ti ve substitutions, the 
longest contiguous stretch of similati ty between these two protein 
sequences was seven . The overall similari ty and identity valu es for 
th ese two sequences, allowing for th e introduction of gaps, were 41% 
and 19.5%, respectively. 
T cells fi·om a subset of PV patients showed a proliferative response 
to the FP-K fu sion protein , and this response was shown to be 
concentration dependent. The results fi·om a representative patient are 
shown in Fig 2a. Of th e eight PV patients rested, T cell proli feration 
to FP-K was observed in samples from four, all of w hom also had 
circulating anti-D sgl autoantibodies, as determined by imm.unoprecipi-
tation. The proEferati ve response of PV T cells to FP-K is presented 
in terms of the stimulation index and is shown in Table I . T his Dsgl 
reactivity was not seen in individuals whose sera onJy recognized Dsg3. 
T cells from this subset of PV patients did not respond to GST or to 
St-1 , a fu sion protein of the BP180 antigen, suggesting that the 
proliferative responses ofT ce!Js of these patients is antigen specific. T 
lymphocytes from other groups of patients (BP, C P, and psoriasis) and 
control indi viduals did not respond to tllis D sgl peptide (not shown) , 
suggesting that the stimulato ry response indu ced by FP-K is specific 
to these PV patients. Moreover, we found that this peptide only 
induced proli feration of CD 4+ (Fig 2b), and not CD8+ (Pig 2c), T 
cell populations. T hese results strongly indicate that both Dsgl and 
Dsg3 parti cipate in the immune responses of this subset of PV patients 
exhibiting anti-Dsgl and anti-D sg3 autoa ntibodies in th eir sera. 
DfSCU SS ION 
It has been weU documented that = 50% ofPV sera possess, in addition 
to anti-D sg3 autoantibodi es, anti -Dsg1 autoantibodies. The vas t major-
ity of these patients show typica.l clinical. and histologic features of PV, 
although on rare occasions patients may undergo a shift from PV to 
PF during the course of their disease (Koulu and Stanley, 1988; lwatsuki 
et a/, 1991). Based on the high sequence homology (55 .9% identity 
over m ost of the ectodomain) exhibited by Dsgl and Dsg3, it has been 
hypothesized that autoantibodies produced by this subset ofPV patients 
reac t with a se t of epitopes shared by Dsg1 and Dsg3; however, it was 
not previously known whether T ce!Js from these PV patients specifically 
respond to Dsgl. 
The data presented here clearly demonstrate that T cells from 
a subset of PV pati ents, showing both anti-Dsg1 and anti-Dsg3 
autoantibodies in th eir sera, proliferate when in cubated with a Dsgl 
fusion protein that encompasses anlino acids 424-51 0. Based on the 
very low sequence similari ty found between the FP-K insert and Dsg3, 
as described in the R esults, it is unlikely that T cells that respond to 
this 87 anlino acid stretch of Dsgl are also reactive with an epitope 
on D sg3. Furtherm.ore, this D sgl segment has been shown to specifi caJJ y 
activa te T ceUs from patients with PF (n = 3) or fogo selvagem (n = 
8) (Lin eta/, 1997a), supporting the notion that th is protein may possess 
the necessary epitopes to stimulate PF T cells. 
T he expression of certain H.LA-DR alleles by these patients as weU 
as the clinical presentation and the reactivity ofT cells and autoantibod-
ies with Dsgl showed no correlation; however, this might, in part, be 
due to the small number of patients that were in vestigated. It is also 
unclear at this time whether the development of imm.une responses to 
Dsgl in these PV patients is related to the duration and / or severity of 
disease. There is, however, a general trend that patients with longer 
duration of PV in this study (over 2- 3 y) are more likely to exhibit a 
T ceU response against Dsgl compared with patients who had th e 
disease for a shorter period (under 2 y; Table 1). 
The specificity of the T cell response to the FP-K Dsgl peptide 
was substantiated by showing that T cells from all eight PV patients 
were unresponsive to recombinant GST, the catTier protein fo r the 
D sgl fusion protein , or St.l , a GST fusion protein containing a 42 
anlino acid segment of the bull ous pemphigoid antigen BP1 80. In 
addition, T cells fi·om o ther co ntrol groups, such as health y individuals 
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and BP, CP, and psoriasis patients, did not respond wh en incubated 
with Dsgl or control antigens, further documenting the specificity of 
the Dsgl-induced T cell response in these PV patients. Although the 
D sg1 responsive T cells from these patients were shown to be CD4+ 
positive, the nature of the cytokine profile that they secrete remains 
under investigation. It is also unknown whether the D sg1-respons.ive 
T cells in this subset of PV patients are pathogenically relevant. 
The epitopes of Dsgl and D sg3 antigens recognized by PV sera are 
known to be localized in the desmosomal core (Karpati et al, 1993; 
Shimizu et al, 1995). M oreover, it has been reported that sera from 
certain PV patients also possess reactivity to desmocollins, another 
group of desmosomal core glycoproteins (Hashimoto et a/, 1995). 
These fmdings suggest that these desm.osomal antigens are exposed to 
the inunune system in PV patients once the acantholytic process splits 
these organelles. T hus, the T and B cellular and humoral response to 
Dsg3 and Dsg1 , in the particular subset ofPV patients reported in this 
paper, may represent concurrent autoimnll!ne reactions to desmosomal 
core antigens that are uncovered during the course of the epidermal 
disease. The initial target epitope that triggers the auto immune response, 
however, remains unknown. It is expected that characterization of this 
initial epitope would be a difficult task du e to th e diversity of the T 
and B cell responses to Dsg3 and Dsgl epitopes and other desmosomal 
antigens. Because the sera of all PV patients recognize D sg3 by 
immunoprecipitation, it may be assumed that th e initia.l T cell immune 
response is directed to an epitope on Dsg3 . ln the course of the disease, 
this autoi11unune response may spread to involve other D sg3 epitopes 
and perhaps other antigen(s) such as Dsg1 and desmocollins that are 
located within the same cellular organelles. T his "determinant 
spreading" phenomenon of inunune responses has been observed 
in other autoimmune diseases such as experimenta.l autoimmune 
encephalomyelitis and spontaneous insulin- dependent diabetes in the 
nonobese diabetic mouse (Lehmann eta/, 1992; Lehmann eta /, 1993; 
Kaufi11an et a/, 1993). Because both D sgl and Dsg3 co-localize to the 
epidermal desmosomal core, it raises the possibili ty that T cells from 
PV patients may recognize Dsg3 and Dsgl in a stepwise manner as 
stated by th e determinant spreading theory. 
This study demonstrates the complexity of autoinm1une responses 
in a particular subset of PV patients and will allow us to further 
characterize the T cell responses in these pati ents. 
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